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Abstract
Purpose This study aimed to evaluate interleukin (IL)-1β
concentrations in maternal serum and in embryo-cultured con-
ditioned media and to correlate these findings with success of
implantation.
Methods A total of 70 infertile women who underwent
in vitro fertilization treatment were studied. IL-1β concentra-
tions were quantified in maternal serum and in embryo
culture-conditioned media on days 1 and 3. The findings were
compared between those who achieved pregnancy and those
who did not.
Results No significant differences were found in IL-1β serum
concentrations between the groups. IL-1β was not detected in
day 1 culture-conditioned medium. On day 3, IL-1β was
quantified in 27 patients, and IL-1β concentrations were sig-
nificantly higher in women who achieved pregnancy than in
those who did not (p<0.001).
Conclusions High IL-1β concentrations in day 3 culture-
conditioned medium in patients who achieve pregnancy after
in vitro fertilization treatment indicate a possible role of em-
bryonic IL-1β in the implantation process.
Keywords Embryo . Implantation . Interleukin-1β . In vitro
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Introduction
The success of growth and implantation of blastocysts is a
complex event that involves maternal and embryonic signals.
The interleukin-1 (IL-1) system comprises the following: two
agonists, IL-1α and IL-1β, an antagonist IL-1RA, and two
receptors, interleukin-1 receptor type I (IL-1R tI) and
interleukin-1 receptor type II (IL-1R tII) [1, 2]. This system
is closely associated with implantation. In humans, IL-1R tI
has been detected in the uterine endometrium from day 23 of
the menstrual cycle and IL-1β mRNA is increased from the
proliferative to the secretory phase [3, 4].
IL-1β triggers the production of IL-8 by the endometrium,
and this increases migration and survival of trophoblastic cells
[5]. IL-1β increases secretion of prostaglandin E2 and leuke-
mia inhibitory factor, as well as the expression of integrin
ανβ3. In addition, the presence of IL-1β has been demonstrat-
ed in the villous cytotrophoblast, the syncytiotrophoblast, and
the endometrial glands of the maternal decidua [6].
A reduction in integrin ανβ3 expression has been observed
in luteal-phase deficiency, infertility of unknown cause, and in
the hydrosalpinges. Interestingly, expression of this integrin is
regulated by IL-1 that is secreted by embryos [7]. In the
mouse, blockage of IL-1R tI with IL-1RA can in turn block
implantation [8].
Capsule High IL-1β concentrations in culture-conditioned medium after
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After the process of in vitro fertilization (IVF), implanta-
tion is positively correlated with high serum IL-1α and IL-1β
concentrations. The implantation rates of patients in assisted
fecundation cycles are higher in women who have greater IL-
1β concentrations in blood on the day of human chorionic
gonadotropin administration [9].
Barañao and colleagues [10] showed that IL-1β quantifi-
cation in embryo culture-conditioned medium at 24 h of fer-
tilization predicts the probability of pregnancy. In contrast,
Seifer et al. [11] reported not having detected IL-1β in two-
to six-cell human embryo supernatants. Another study
showed that IL-1β mRNA expression was undetectable at
the two-cell stage and was surprisingly low in the morula
and blastocyst in mouse embryos [12]. De los Santos [13]
demonstrated the presence of the whole IL-1 system in the
embryo by means of immunohistochemistry. However, these
authors were only able to find IL-1β secretion in the superna-
tant of embryos when these were co-cultured with epithelial-
endometrial cells during all developmental stages.
Currently, the significance of serum IL-1β concentrations
during the IVF cycle has not yet been completely clarified.
Additionally, the presence of IL-1β in culture-conditioned
medium of embryos under development and its possible rela-
tionship with the mechanism of implantation are unclear.
Therefore, this study aimed to evaluate the association of se-
rum IL-1β concentrations, as well as those in embryo culture
medium, with success of implantation.
Materials and methods
A prospective cohort study was carried out at the National
Institute of Perinatology between April 2011 and July 2012.
The study was approved by the ethics and research commit-
tees. Women younger than 40 years of age, about to undergo
IVF treatment, were invited to participate. Written informed
consent was obtained from all of the patients who were en-
rolled in the study.
We collected two 3-mL samples of peripheral blood. The
first sample was collected on day 1 of the cycle when the
patient’s basal hormone values were quantified. The second
sample was collected on the day that two follicles >18 mm
were observed, immediately prior to the injection of chorionic
gonadotropin (last day of hormone stimulation).
Controlled ovarian hyperstimulation was initiated on day 2
of the menstrual cycle, using two alternative schemes: (1)
recombinant human follicle-stimulating hormone (Gonal-F;
Merck Serono, Germany) or (2) recombinant human follicle-
stimulating hormone and urinary menotropins (Merapur;
Ferring Pharmaceuticals, Switzerland). The ovarian stimula-
tion protocol was selected by each treating physician as fol-
lows: (1) a long standard protocol with a gonadotropin-
releasing agonist (Lucrin; Abbott, USA) in only six patients
or (2) a flexible antagonist protocol (Cetrotide; Merck Serono,
Germany) in 58 patients. No patients were transferred when
estradiol levels were greater than 3500 pg/ml or progesterone
levels were greater than 0.15 ng/ml.
For IL-1β quantification in serum, peripheral blood was
centrifuged at 3000 rpm for 5 min. The serum was collected
and frozen at −70 °C for later processing.
The oocytes were analyzed in the Assisted Reproduction
Laboratory to define their morphological state and were incu-
bated for approximately 4 h prior to fertilization. Standard IVF
and intracytoplasmic sperm injection were performed. After
fertilization, the zygotes were cultured in G-1TM/G-1TM
PLuS medium (Vitrolife, San Diego CA, USA). The culture
media were recovered at 24 and 72 h after fertilization. On day
3 prior to embryo transfer, we carried out morphological eval-
uation of the embryos using the Lucinda Veeck classification
[14]. The embryos were categorized based on morphological
evaluation into three groups: only top (qualities 1, 2 according
to Lucinda Veeck classification), top and non-top (qualities 1,
2, 3, 4), and only non-top (qualities 3, 4).
Each embryo was cultured separately, but samples were the
result of a pooled medium culture of two or three embryos.
Culture media were mixed because we needed a minimum of
15 μL for testing. Therefore, those patients who achieved a
unique embryo and patients who failed to be transferred were
excluded (n=6). We included only patients with two or three
transferred embryos. These samples were immediately frozen
at −70 °C for later processing.
IL-1β concentrations were quantified by the enzyme-
linked immunosorbent assay technique (cat. DY401;
R&D Systems, USA) using 100 μL of serum or the
total volume of the embryo medium culture mixture. A
standard curve of 1.5–50 pg/mL with a sensitivity limit
of 0.1 pg/mL was used to calculate IL-1β concentra-
tions. Inter- and intra-assay coefficients of variation
were <10 %. An absorbance reading was taken at
450 nm (Synergy™ HT; BioTek Instruments, Winooski,
VT, USA).
Pregnancy or successful implantation was considered in
patients who were positive for beta human chorionic gonado-
tropin (1 mIU/ml) 14 days post-transfer of embryos.
The results are expressed as mean ± standard error of the
mean. Differences between groups were compared by the




The total number of patients studied was 64. All of the patients
were Mexicans with a mean age of 34±3 years. The threshold
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estradiol level on the day of human chorionic gonadotropin
administration was 1582±550 pg/ml. No correlation between
the quantification of IL-1β and serum estradiol (p=0.39) was
found. The baseline characteristics of the patients are shown in
Table 1. The group of women who achieved pregnancy was
compared with the group of women who failed to do so. There
were no significant differences in baseline characteristics be-
tween the two groups.
Standard IVF was performed in 44 (68.8 %) patients and
intracytoplasmic sperm injection in 20 (31.3 %). The study
participants were divided into two groups: 29 patients had a
successful implantation or pregnancy and 35 patients did not
achieve pregnancy. In the group of patients who failed to get
pregnant, a total of 80 embryos were transferred, while in the
group that achieved pregnancy, 95 embryos were transferred.
Quantification of IL-1β concentrations inmaternal serum
Serum quantification of IL-1β at initiation of treatment on day
1 was 0 pg/mL in 96.8% (n=62) of patients. In serum samples
from the last day of controlled ovarian hyperstimulation, 47
patients (73 %) had detectable IL-1β concentrations, with a
mean concentration of 39.5±10.3 pg/mL. No difference in IL-
1β concentrations was found between patients who achieved
pregnancy and those that failed to do so (52.7±22.0 vs. 28.7±
5.2 pg/mL; p=0.29).






Age (years): median (min-max) 34 (22–28) 34 (27–39) 493 −0.91 0.42
BMI (kg/m2): median (min-max) 24.6 (17–32) 24.3 (17–29) 484 −0.31 0.37
Years of infertility: median (min-max) 5 (1–8) 7 (3–8) 427 −1.08 0.13
Follicles >18 mm: median (min-max) 7 (3–14) 5 (3–18) 466 −0.56 0.28
Estradiol (pg/ml) the day of hCG median (min-max) 1386 (1109–2548) 1633 (820–3394) 495 −0.16 0.43
Number or embryos transferred: 485 −0.39 0.34
2: n (%) 7 (24.1) 10 (28.6)
3: n (%) 22 (75.9) 25 (71.4)
Quality of transfer embryos: 395 −1.81 0.79
Only top (quality 1, 2): n (%) 22 (75.9) 20 (57.1)
Top and non-top (quality 1, 2, 3, 4): n (%) 7 (24.1) 10 (28.6)
Only non-top (quality 3, 4): n (%) 0 (0.0) 5 (14.3)
Mann–Whitney U test. BMI body mass index, hCG human chorionic gonadotropin. No significant differences were found between the two groups
Fig. 1 Box and whisker plot
shows IL-1β concentrations in
embryo culture medium at day 3
and their relation to successful
implantation. No pregnancy, n=
35; pregnancy, n=29. The results
are expressed as mean ± standard
error of the mean. Boxes represent
the median, and the 25th and 75th
percentiles. Asterisk indicates a
significant difference (p<0.001)
between the two groups of IVF
patients
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Quantification of IL-1β concentrations in embryo
culture-conditioned medium
On day 1 post-fertilization, we did not detect IL-1β concen-
trations (0 pg/mL in 64 patients). The percentage of detection
of IL-1β concentrations on day 3 of embryo development was
42% (27 patients), with a mean concentration of 4.1±0.82 pg/
mL.
We found that IL-1β concentrations of embryo superna-
tants of patients who achieved pregnancy were significantly
higher than those in patients who did not achieve pregnancy
(8.5±1.4 vs. 0.55±0.25 pg/mL; p<0.001; Fig. 1).
Discussion
One of the major issues in IVF is why patients who are sub-
mitted to repeated cycles of IVF with transfer of apparently
good-quality embryos do not achieve pregnancy. This inexpli-
cable failure in implantation is the basis of the current study.
Our study failed to detect any significant differences
in serum IL-1β concentrations after stimulation of hormones.
Karagouni et al. [9] detected serum IL-1β concentrations in
58 % of 33 patients with post-hCG concentrations of 68.5±
24.6 pg/mL in pregnant women and 20.5±13.4 pg/mL in
women without pregnancy. The reason for this difference be-
tween studies could be because hCG stimulates IL-1β secre-
tion. In the present study, IL-1βwas quantified after hormonal
stimulation and prior to hCG administration to determine if
elevation of IL-1β could have been related to the administra-
tion of FSH/MHG alone. Our findings indicated that con-
trolled ovarian hyperstimulation induces systemic production
of IL-1β. Therefore, IL-1β may have a regulatory effect on
previous administration of hCG.
Our study showed IL-1β concentrations in embryo medi-
um culture on day 3 of development and their correlation with
pregnancy. Previous studies have suggested that embryos are
not capable of secreting IL-1β if they are not co-cultured with
endothelial cells. However, we were able to detect IL-1β in
embryo medium culture at 3 days of development (eight cells)
[13].
Notably, even though we did not achieve detection of IL-
1β in a high proportion of patients, those who were positive
showed an association between IL-1β concentrations and
pregnancy. This finding suggested that IL-1β production
could play an important role in the implantation process.
Barañao et al. [10] reported IL-1β concentrations of 49±
7 pg/mL in embryo culture supernatant at 24 h, but we did not
find a detectable amount of IL-1β on day 1. This difference
between studies may be due to the fact that we cultured single
embryos per well and Barañao et al. [10] cultured a mean
number of 5±1 embryos per well. However, our finding is
in agreement with that reported by Seifer et al. [11] who did
not achieve quantification of IL-1β of two- to six-cell human
embryo supernatants (on days 1 and 2). Our finding is also
consistent with that reported in mice by Kruessel and col-
leagues, who did not find mRNA expression of IL-1β in the
two-cell stage [12].
Four of the 37 patients who were negative for IL-1β in day
3 supernatants achieved pregnancy. The use of pooled media
limited the level of the analysis because we quantified mean
IL-1β production of two or three embryos and not individual
IL-1β production. However, we consider that IL-1β synthesis
could have started later in these embryos without impairing
the implantation process.
While the IL-1 system is known to be associated with im-
plantation, various questions with respect to its regulation still
remain. Knowledge of the normal expression patterns of this
cytokine can aid in predicting success in implantation, in
selecting the embryos to be transferred in IVF programs, and
in increasing the success of pregnancy.
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